Products

Find the artificial intelligence based software for pathology that you are looking for. All products listed are available for the European market (CE-IVD marked).

The data presented in the pathology domain is under a publication embargo until May 2026 and should not be used for publication purposes until the embargo period has ended.

1 of 105 products

1/105

products

|

Sort by:

Search
Filters
Modality

(1)

Subspeciality

(1)

FDA Pathway
FDA Class
CE-IVD Pathway

(1)

CE-IVD Class

(1)

Company

(1)

AI Platforms (1)

(26)

(1)

(6)

(1)

(5)

Visiopharm logo

Subspeciality: Breast pathology

Modality: Histopathology

Source: Vendor

Calculation of the proliferation index, Counting of all tumor cells, Counting of positively stained tumor cells

Our Ki-67 solution for breast cancer is fully automated and does not require manual input during analysis. The solution consists of four automated analysis steps. Once started, it automatically separates the sample tissue from control tissues and robustly identifies invasive cancer areas in the sample. Tumor nuclei are counted based on their Ki-67 expression and the resulting proliferation index for the whole tumor area is calculated.